Skip to content

Food and Education Effects on Diabetes Study

Impact of Medically-tailored Meals on Health Care Outcomes and Costs Among Low-income Adults With Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04034511
Acronym
FEED
Enrollment
74
Registered
2019-07-26
Start date
2020-01-21
Completion date
2023-09-30
Last updated
2023-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

nutrition, medically-tailored meals

Brief summary

Low-income adults are disproportionately affected by diabetes, experiencing greater rates of diabetes, diabetes-related complications, and mortality. Dietary habits play an important role in achieving and maintaining glycemic control to improve health outcomes. However, low-income adults are less likely to adopt the necessary dietary changes to improve glycemic control largely due to poor access to care, limited knowledge and skills to facilitate lifestyle change, and financial and environmental constraints that limit access to healthy foods. Nutrition interventions that target key barriers to healthy dietary habits among low-income adults with diabetes may have a profound impact on improving glycemic control. The provision of home-delivered, medically-tailored meals in addition to individualized medical nutrition therapy is a promising approach to improve dietary habits in socially disadvantaged populations with diabetes. Evidence suggests the provision of medically tailored meals may be beneficial in improving health outcomes and health care costs among socially disadvantaged adults with chronic illnesses, however rigorous studies specifically exploring the benefits of meal provision and medical nutrition therapy among adults with type 2 diabetes are lacking. The investigators aim to conduct a randomized-controlled clinical trial examining the impact of medically-tailored meals and medical nutrition therapy on health-related outcomes and health care costs among low-income adults with type 2 diabetes.

Detailed description

The investigators will recruit 100 individuals age 18 and over with uncontrolled diabetes (defined as a hemoglobin A1c (HbA1c) \>8%) and enrolled in Priority Partners Medicaid insurance. Participants will be randomized to one of two groups: 1) 3 months of home-delivered, medically-tailored meals combined with monthly individual Medical Nutrition Therapy sessions for 6 months or 2) usual care. The investigators will follow participants for up to 12 months to assess for changes in hemoglobin A1c.

Interventions

OTHERMedically-tailored meal delivery and medical nutrition therapy

Home-delivered, medically-tailored meals for 3 months combined with monthly individual medical nutrition therapy sessions for 6 months

Sponsors

Moveable Feast
CollaboratorUNKNOWN
Priority Partners MCO
CollaboratorUNKNOWN
Leonard & Helen R. Stulman Charitable Foundation
CollaboratorUNKNOWN
France-Merrick Foundation
CollaboratorUNKNOWN
Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

The outcome assessor and data-analyst will be masked to treatment assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 and over * Diabetes with a hemoglobin A1c\>8% * Medicaid beneficiary * Enrolled in Medicaid Insurance

Exclusion criteria

* Medical conditions that are indications for additional dietary requirements (e.g., advanced chronic kidney disease, end-stage renal disease, chronic wounds, or severe alcohol use disorder) * Swallowing difficulties * Food allergies * Non-English speaking * Language or hearing impairment * Currently pregnant or breast feeding * Does not have a refrigerator/freezer in the home to store meals * Has plans to move out of the meal delivery service area in the next 12 months

Design outcomes

Primary

MeasureTime frameDescription
Change in hemoglobin A1cBaseline, 6 monthsChange in hemoglobin A1c (percent)

Secondary

MeasureTime frameDescription
Change in Hemoglobin A1cBaseline, 12 monthsChange in Hemoglobin A1c (percent)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026